Prostate cancer is a localized disease for the majority of patients. However, local or distant
relapse presents a major health burden for a number of men each year. Androgen …

In this case report, we are reporting the case of a 68‐year‐old male patient who was
admitted in our hospital for unintended weight loss, asthenia, and anorexia. Physical …

Small extracellular vesicles (sEVs) are nanovesicles secreted from cells, that elicit
intercellular communication by transferring their cargo to recipient cells. This form of …

The present invention concerns methods for treating a proliferation disorder, such as
prostate cancer, basal cell carcinoma, lung cancer, and other cancers, using an inhibitor of …

Using of ginsenoside M1 for treatment in particular cancer, including melanoma and
prostate cancer. Specifically, it relates to ginsenoside Mi for use in inhibiting growth and …

Metastatic disease is the leading cause of death in cancer patients. Despite significant
advancement in understanding the pathological process at cellular and molecular level …

BACKGROUND AND OBJECTIVE: Prostate adenocarcinoma is the most common neoplasm
in men. The most common metastatic sites are usually bones, lung and pelvic lymph nodes …

BACKGROUND AND OBJECTIVE: The testis is a rare site for prostate cancer metastases
and is usually found in autopsies or incidentally after therapeutic orchiectomies. The …

Pharmacy practice has changed significantly lately. The professionals have the chance to
contribute straightforwardly to patient consideration so as to lessen morbimortality identified …

IκB kinase subunit alpha (IKKalpha), a key component of the NFκB pathway, is implicated in
prostate cancer progression and bone remodelling, but its role in the regulation of prostate …